For some women with early breast tumors, lower-dose chemotherapy and the drug Herceptin may help ward off a cancer recurrence, a new study suggests. Experts said the findings, published in the Jan. 8 New England Journal of Medicine , could offer the first standard treatment approach for women in the early stages of HER2-positive breast cancer.

Click here to read original article